Ilsoon Yang

Leads credit policy development of credit line strategies, authorizations and re-pricing strategies for existing non-prime credit card customers. Provide consultation for risk model development, account monitoring techniques, automated underwriting strategies, quantitative financial analysis and/or potential risk management programs for new ventures.

Directed profit & loss forecast of acquisition and account management programs and developed data-driven business targeting strategies (segmentation, pricing and offer strategies) for rewards portfolios.

Developed analytical methodologies to evaluate clinical data on “Quality-of-Life” for oncology, asthma, and allergy studies to support drug approvals from FDA (Food and Drug Administration).